Davidson & Garrard’s Celgene CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Davidson & Garrard's CELG Position: Q3 2017 in Review
Davidson & Garrard increased its Celgene (CELG) stake by 6.3% in Q3 2017, buying an estimated $99.4K and bringing the position to 12,333 shares worth $1.8M. The position accounts for 0.42% of the portfolio, ranked #71.
Davidson & Garrard first reported a position in CELG in Q2 2016 and has held it in 6 quarters since. 1,485 funds tracked by Wall St. Rank hold CELG as of Q3 2017.
- Davidson & Garrard held 12,333 shares of Celgene worth $1.8M as of Q3 2017.
- Davidson & Garrard bought 730 Celgene shares in Q3 2017, an estimated $99.4K.
- Celgene made up 0.42% of Davidson & Garrard's portfolio in Q3 2017, its #71 holding.
- Davidson & Garrard first reported a position in Celgene in Q2 2016 and has held it in 6 quarters since.
- 1,485 funds tracked by Wall St. Rank held Celgene as of Q3 2017.
Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.